A new presidential administration and administrator may impact the Food and Drug Administration and its approval of drugs and medications. The FDA faced serious challenges and pressure to authorize unproven drugs during the pandemic. It must address other issues...
Year: 2021
Creditor protection during bankruptcy
During the current difficult economic climate, businesses in distress are being forced to merge, liquidate or restructure debt in order to stay afloat. Creditors should know that they have rights, however, in the event of a corporate bankruptcy proceeding. It is...
Creditors’ rights and fraudulent conveyances
As a creditor, bankruptcy poses a very real risk. After all, a successful bankruptcy discharge could leave your bottom line hurting, in some instances significantly so. To protect your interests as fully as possible, you need to do everything you can to increase the...
How remote communication is shaping mediation
With the world changing its business, learning and even social communication to remote platforms, it is worth taking a second look at how these technologies can reshape the mediation process as well. Because remote mediation requires a great deal of advanced planning,...
New Jersey company agrees with government on COVID drug
When there is an ongoing health crisis, biotech and pharmaceutical companies come to the forefront in finding solutions to help treat it. That has rarely been more evident than with the current coronavirus outbreak that has sickened many, led to significant deaths and...